Major signaling pathways and key mediators of macrophages in acute kidney injury (Review)
- Authors:
- Ning Li
- Jiale Chen
- Pengtao Wang
- Haojun Fan
- Shike Hou
- Yanhua Gong
-
Affiliations: Institute of Disaster Medicine, Tianjin University, Tianjin 300072, P.R. China, Tianjin Key Laboratory of Disaster Medicine Technology, Tianjin 300072, P.R. China - Published online on: April 16, 2021 https://doi.org/10.3892/mmr.2021.12094
- Article Number: 455
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Messerer DAC, Halbgebauer R, Nilsson B, Pavenstädt H, Radermacher P and Huber-Lang M: Immunopathophysiology of trauma-related acute kidney injury. Nat Rev Nephrol. 17:91–111. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Eppensteiner J, Davis RP, Barbas AS, Kwun J and Lee J: Immunothrombotic activity of damage-associated molecular patterns and extracellular vesicles in secondary organ failure induced by trauma and sterile insults. Front Immunol. 9:1902018. View Article : Google Scholar : PubMed/NCBI | |
|
Wynn TA, Chawla A and Pollard JW: Macrophage biology in development, homeostasis and disease. Nature. 496:445–455. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ginhoux F and Guilliams M: Tissue-resident macrophage ontogeny and homeostasis. Immunity. 44:439–449. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, Garner H, Trouillet C, de Bruijn MF, Geissmann F and Rodewald HR: Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. 518:547–551. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Okabe Y and Medzhitov R: Tissue biology perspective on macrophages. Nat Immunol. 17:9–17. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SY and Nair MG: Macrophages in wound healing: Activation and plasticity. Immunol Cell Biol. 97:258–267. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wynn TA and Vannella KM: Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 44:450–462. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Vannella KM and Wynn TA: Mechanisms of organ injury and repair by macrophages. Annu Rev Physiol. 79:593–617. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Stein M, Keshav S, Harris N and Gordon S: Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. J Exp Med. 176:287–292. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Chen T, Cao Q, Wang Y and Harris DCH: M2 macrophages in kidney disease: Biology, therapies, and perspectives. Kidney Int. 95:760–773. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Verdeguer F and Aouadi M: Macrophage heterogeneity and energy metabolism. Exp Cell Res. 360:35–40. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Smigiel KS and Parks WC: Macrophages, wound healing, and fibrosis: Recent insights. Curr Rheumatol Rep. 20:172018. View Article : Google Scholar : PubMed/NCBI | |
|
Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT and Sahebkar A: Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 233:6425–6440. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Funes SC, Rios M, Escobar-Vera J and Kalergis AM: Implications of macrophage polarization in autoimmunity. Immunology. 154:186–195. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Levey AS and James MT: Acute kidney injury. Ann Intern Med. 167:ITC66–ITC80. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gameiro J, Fonseca JA, Outerelo C and Lopes JA: Acute kidney injury: From diagnosis to prevention and treatment strategies. J Clin Med. 9:17042020. View Article : Google Scholar : PubMed/NCBI | |
|
Stewart IJ, Sosnov JA, Howard JT and Chung KK: Acute kidney injury in critically injured combat veterans: A retrospective cohort study. Am J Kidney Dis. 68:564–570. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Rahbar Saadat Y, Hosseiniyan Khatibi SM, Ardalan M, Barzegari A and Zununi Vahed S: Molecular pathophysiology of acute kidney injury: The role of sirtuins and their interactions with other macromolecular players. J Cell Physiol. 236:3257–3274. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Maekawa H, Inoue T, Ouchi H, Jao TM, Inoue R, Nishi H, Fujii R, Ishidate F, Tanaka T, Tanaka Y, et al: Mitochondrial damage causes inflammation via cGAS-STING signaling in acute kidney injury. Cell Rep. 29:1261–1273.e6. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ward DB and Valentovic MA: Contrast induced acute kidney injury and direct cytotoxicity of iodinated radiocontrast media on renal proximal tubule cells. J Pharmacol Exp Ther. 370:160–171. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Bellomo R, Kellum JA and Ronco C: Acute kidney injury. Lancet. 380:756–766. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Zhang C, Li J, Niyazi S, Zheng L, Xu M, Rong R, Yang C and Zhu T: Erythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization. Cell Death Dis. 8:e27252017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou L, Zhuo H, Ouyang H, Liu Y, Yuan F, Sun L, Liu F and Liu H: Glycoprotein non-metastatic melanoma protein b (Gpnmb) is highly expressed in macrophages of acute injured kidney and promotes M2 macrophages polarization. Cell Immunol. 316:53–60. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wu J, Wan X, Zhang H, Li W, Ma M, Pan B, Liang X and Cao C: Retinoic acid attenuates contrast-induced acute kidney injury in a miniature pig model. Biochem Biophys Res Commun. 512:163–169. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Huen SC and Cantley LG: Macrophage-mediated injury and repair after ischemic kidney injury. Pediatr Nephrol. 30:199–209. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Jang HR and Rabb H: Immune cells in experimental acute kidney injury. Nat Rev Nephrol. 11:88–101. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Huen SC and Cantley LG: Macrophages in renal injury and repair. Annu Rev Physiol. 79:449–469. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Han HI, Skvarca LB, Espiritu EB, Davidson AJ and Hukriede NA: The role of macrophages during acute kidney injury: Destruction and repair. Pediatr Nephrol. 34:561–569. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Singbartl K, Formeck CL and Kellum JA: Kidney-immune system crosstalk in AKI. Semin Nephrol. 39:96–106. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Mu G, Song C, Zhou L, He L, Jin Q and Lu Z: Role of M2 Macrophages in Sepsis-induced acute kidney injury. Shock. 50:233–239. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Mao R, Wang C, Zhang F, Zhao M, Liu S, Liao G, Li L, Chen Y, Cheng J, Liu J and Lu Y: Peritoneal M2 macrophage transplantation as a potential cell therapy for enhancing renal repair in acute kidney injury. J Cell Mol Med. 24:3314–3327. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Kim MG, Lim K, Lee YJ, Yang J, Oh SW, Cho WY and Jo SK: M2 macrophages predict worse long-term outcomes in human acute tubular necrosis. Sci Rep. 10:21222020. View Article : Google Scholar : PubMed/NCBI | |
|
Baek JH: The impact of versatile macrophage functions on acute kidney injury and its outcomes. Front Physiol. 10:10162019. View Article : Google Scholar : PubMed/NCBI | |
|
Wu H, Wang Y, Zhang Y, Xu F, Chen J, Duan L, Zhang T, Wang J and Zhang F: Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress. Redox Biol. 32:1015002020. View Article : Google Scholar : PubMed/NCBI | |
|
Yao W, Guo A, Han X, Wu S, Chen C, Luo C, Li H, Li S and Hei Z: Aerosol inhalation of a hydrogen-rich solution restored septic renal function. Aging (Albany NY). 11:12097–12113. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kaneda MM, Messer KS, Ralainirina N, Li H, Leem CJ, Gorjestani S, Woo G, Nguyen AV, Figueiredo CC, Foubert P, et al: PI3Kγ is a molecular switch that controls immune suppression. Nature. 539:437–442. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Qin S, Li J, Zhou C, Privratsky B, Schettler J, Deng X, Xia Z, Zeng Y, Wu H and Wu M: SHIP-1 regulates phagocytosis and M2 polarization through the PI3K/Akt-STAT5-Trib1 circuit in pseudomonas aeruginosa infection. Front Immunol. 11:3072020. View Article : Google Scholar : PubMed/NCBI | |
|
Duan Y, Zheng H, Li Z, Yao Y, Ding J, Wang X, Nakkala JR, Zhang D, Wang Z, Zuo X, et al: Unsaturated polyurethane films grafted with enantiomeric polylysine promotes macrophage polarization to a M2 phenotype through PI3K/Akt1/mTOR axis. Biomaterials. 246:1200122020. View Article : Google Scholar : PubMed/NCBI | |
|
An C, Wen J, Hu Z, Mitch WE and Wang Y: Phosphoinositide 3-kinase γ deficiency attenuates kidney injury and fibrosis in angiotensin II-induced hypertension. Nephrol Dial Transplant. 35:1491–1500. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Amano MT, Castoldi A, Andrade-Oliveira V, Latancia MT, Terra FF, Correa-Costa M, Breda CNS, Felizardo RJF, Pereira WO, da Silva MB, et al: The lack of PI3Kγ favors M1 macrophage polarization and does not prevent kidney diseases progression. Int Immunopharmacol. 64:151–161. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liu C, Li B, Tang K, Dong X, Xue L, Su G and Jin Y: Aquaporin 1 alleviates acute kidney injury via PI3K-mediated macrophage M2 polarization. Inflamm Res. 69:509–521. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Markó L, Vigolo E, Hinze C, Park JK, Roël G, Balogh A, Choi M, Wübken A, Cording J, Blasig IE, et al: Tubular epithelial NF-kappaB activity regulates ischemic AKI. J Am Soc Nephrol. 27:2658–2669. 2016. View Article : Google Scholar | |
|
Huang RS, Zhou JJ, Feng YY, Shi M, Guo F, Gou SJ, Salerno S, Ma L and Fu P: Pharmacological inhibition of macrophage toll-like receptor 4/Nuclear Factor-kappa B alleviates rhabdomyolysis-induced acute kidney injury. Chin Med J (Engl). 130:2163–2169. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Shu B, Feng Y, Gui Y, Lu Q, Wei W, Xue X, Sun X, He W, Yang J and Dai C: Blockade of CD38 diminishes lipopolysaccharide-induced macrophage classical activation and acute kidney injury involving NF-κB signaling suppression. Cell Signal. 42:249–258. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Quan F, Cao Q, Lin Y, Yue C, Bi R, Cui X, Yang H, Yang Y, Birnbaumer L, et al: Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J Adv Res. 28:231–243. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lu H, Wu L, Liu L, Ruan Q, Zhang X, Hong W, Wu S, Jin G and Bai Y: Quercetin ameliorates kidney injury and fibrosis by modulating M1/M2 macrophage polarization. Biochem Pharmacol. 154:203–212. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Tan RZ, Wang C, Deng C, Zhong X, Yan Y, Luo Y, Lan HY, He T and Wang L: Quercetin protects against cisplatin-induced acute kidney injury by inhibiting Mincle/Syk/NF-κB signaling maintained macrophage inflammation. Phytother Res. 34:139–152. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Tan RZ, Liu J, Zhang YY, Wang HL, Li JC, Liu YH, Zhong X, Zhang YW, Yan Y, Lan HY and Wang L: Curcumin relieved cisplatin-induced kidney inflammation through inhibiting Mincle-maintained M1 macrophage phenotype. Phytomedicine. 52:284–294. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hui D, Rui-Zhi T, Jian-Chun L, Xia Z, Dan W, Jun-Ming F and Li W: Astragalus propinquus Schischkin and Panax notoginseng (A&P) compound relieved cisplatin-induced acute kidney injury through inhibiting the mincle maintained macrophage inflammation. J Ethnopharmacol. 252:1126372020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Bai Y, Jiang Y, Tarun P, Feng Y, Huang R and Fu P: Immunomodulatory role of recombinant human erythropoietin in acute kidney injury induced by crush syndrome via inhibition of the TLR4/NF-κB signaling pathway in macrophages. Immunopharmacol Immunotoxicol. 42:37–47. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu P, Shen P, Yu B, Xu X, Ge R, Cheng X, Chen Q, Bian J, Li Z and Wang J: Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. Eur J Med Chem. 192:1121552020. View Article : Google Scholar : PubMed/NCBI | |
|
Bousoik E and Montazeri Aliabadi H: ‘Do We Know Jack’ About JAK? A closer Look at JAK/STAT signaling pathway. Front Oncol. 8:2872018. View Article : Google Scholar : PubMed/NCBI | |
|
Banerjee S, Biehl A, Gadina M, Hasni S and Schwartz DM: JAK-STAT signaling as a target for inflammatory and autoimmune diseases: Current and future prospects. Drugs. 77:521–546. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu M, Wang L, Yang J, Xie K, Zhu M, Liu S, Xu C, Wang J, Gu L, Ni Z, et al: Erythropoietin ameliorates lung injury by accelerating pulmonary endothelium cell proliferation via janus kinase-signal transducer and activator of transcription 3 pathway after kidney ischemia and reperfusion injury. Transplant Proc. 51:972–978. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang MZ, Wang X, Wang Y, Niu A, Wang S, Zou C and Harris RC: IL-4/IL-13-mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury. Kidney Int. 91:375–386. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
van der Lienden MJC, Gaspar P, Boot R, Aerts JMFG and van Eijk M: Glycoprotein non-metastatic protein B: An emerging biomarker for lysosomal dysfunction in macrophages. Int J Mol Sci. 20:662018. View Article : Google Scholar : PubMed/NCBI | |
|
Kim EK and Choi EJ: Compromised MAPK signaling in human diseases: An update. Arch Toxicol. 89:867–882. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ren Q, Guo F, Tao S, Huang R, Ma L and Fu P: Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. Biomed Pharmacother. 122:1097722020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun S, Wang J, Wang J, Wang F, Yao S and Xia H: Maresin 1 mitigates sepsis-associated acute kidney injury in mice via inhibition of the NF-κB/STAT3/MAPK pathways. Front Pharmacol. 10:13232019. View Article : Google Scholar : PubMed/NCBI | |
|
Wen Y and Parikh CR: Current concepts and advances in biomarkers of acute kidney injury. Crit Rev Clin Lab Sci. 1–24. 2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI | |
|
Tian L, Shao X, Xie Y, Wang Q, Che X, Zhang M, Xu W, Xu Y, Mou S and Ni Z: Kidney injury molecule-1 is elevated in nephropathy and mediates macrophage activation via the mapk signalling pathway. Cell Physiol Biochem. 41:769–783. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li B, Liu C, Tang K, Dong X, Xue L, Su G, Zhang W and Jin Y: Aquaporin-1 attenuates macrophage-mediated inflammatory responses by inhibiting p38 mitogen-activated protein kinase activation in lipopolysaccharide-induced acute kidney injury. Inflamm Res. 68:1035–1047. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Conserva MR, Anelli L, Zagaria A, Specchia G and Albano F: The pleiotropic role of retinoic acid/retinoic acid receptors signaling: From vitamin A metabolism to gene rearrangements in acute promyelocytic leukemia. Int J Mol Sci. 20:29212019. View Article : Google Scholar : PubMed/NCBI | |
|
Cunningham TJ and Duester G: Mechanisms of retinoic acid signalling and its roles in organ and limb development. Nat Rev Mol Cell Biol. 16:110–123. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ghyselinck NB and Duester G: Retinoic acid signaling pathways. Development. 146:dev1675022019. View Article : Google Scholar : PubMed/NCBI | |
|
Vellozo NS, Pereira-Marques ST, Cabral-Piccin MP, Filardy AA, Ribeiro-Gomes FL, Rigoni TS, DosReis GA and Lopes MF: All-Trans Retinoic Acid Promotes an M1- to M2-Phenotype shift and inhibits macrophage-mediated immunity to leishmania major. Front Immunol. 8:15602017. View Article : Google Scholar : PubMed/NCBI | |
|
Chiba T, Skrypnyk NI, Skvarca LB, Penchev R, Zhang KX, Rochon ER, Fall JL, Paueksakon P, Yang H, Alford CE, et al: Retinoic acid signaling coordinates macrophage-dependent injury and repair after AKI. J Am Soc Nephrol. 27:495–508. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Brilli Skvarca L, Han HI, Espiritu EB, Missinato MA, Rochon ER, McDaniels MD, Bais AS, Roman BL, Waxman JS, Watkins SC, et al: Enhancing regeneration after acute kidney injury by promoting cellular dedifferentiation in zebrafish. Dis Model Mech. 12:dmm0373902019. View Article : Google Scholar : PubMed/NCBI | |
|
Harris J, VanPatten S, Deen NS, Al-Abed Y and Morand EF: Rediscovering MIF: New tricks for an old cytokine. Trends Immunol. 40:447–462. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kang I and Bucala R: The immunobiology of MIF: Function, genetics and prospects for precision medicine. Nat Rev Rheumatol. 15:427–437. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Calandra T and Roger T: Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol. 3:791–800. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Averdunk L, Bernhagen J, Fehnle K, Surowy H, Lüdecke HJ, Mucha S, Meybohm P, Wieczorek D, Leng L, Marx G, et al: The macrophage migration inhibitory factor (MIF) promoter polymorphisms (rs3063368, rs755622) predict acute kidney injury and death after cardiac surgery. J Clin Med. 9:29362020. View Article : Google Scholar : PubMed/NCBI | |
|
Hong MY, Tseng CC, Chuang CC, Chen CL, Lin SH and Lin CF: Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritis. Mediators Inflamm. 2012:3813582012. View Article : Google Scholar : PubMed/NCBI | |
|
Wu B, Chen J and Yang Y: Biomarkers of acute kidney injury after cardiac surgery: A narrative review. Biomed Res Int. 2019:72986352019. View Article : Google Scholar : PubMed/NCBI | |
|
Fuhrman DY and Kellum JA: Epidemiology and pathophysiology of cardiac surgery-associated acute kidney injury. Curr Opin Anaesthesiol. 30:60–65. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Stoppe C, Averdunk L, Goetzenich A, Soppert J, Marlier A, Kraemer S, Vieten J, Coburn M, Kowark A, Kim BS, et al: The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery. Sci Transl Med. 10:eaan48862018. View Article : Google Scholar : PubMed/NCBI | |
|
Leaver SK, MacCallum NS, Pingle V, Hacking MB, Quinlan GJ, Evans TW and Burke-Gaffney A: Increased plasma thioredoxin levels in patients with sepsis: Positive association with macrophage migration inhibitory factor. Intensive Care Med. 36:336–341. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Nishida K, Watanabe H, Ogaki S, Kodama A, Tanaka R, Imafuku T, Ishima Y, Chuang VT, Toyoda M, Kondoh M, et al: Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury. Sci Rep. 5:144712015. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Tang Y, Tang PMK, Lv J, Huang XR, Carlsson-Skwirut C, Da Costa L, Aspesi A, Fröhlich S, Szczęśniak P, et al: Blocking macrophage migration inhibitory factor protects against cisplatin-induced acute kidney injury in mice. Mol Ther. 26:2523–2532. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Li JH, Tang Y, Lv J, Wang XH, Yang H, Tang PMK, Huang XR, He ZJ, Zhou ZJ, Huang QY, et al: Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion. J Cell Mol Med. 23:3867–3877. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lv J, Huang XR, Klug J, Fröhlich S, Lacher P, Xu A, Meinhardt A and Lan HY: Ribosomal protein S19 is a novel therapeutic agent in inflammatory kidney disease. Clin Sci (Lond). 124:627–637. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Matsushita T and Takehara K: Soluble CD163 is a potential biomarker in systemic sclerosis. Expert Rev Mol Diagn. 19:197–199. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Mejia-Vilet JM, Zhang XL, Cruz C, Cano-Verduzco ML, Shapiro JP, Nagaraja HN, Morales-Buenrostro LE and Rovin BH: Urinary soluble CD163: A novel noninvasive biomarker of activity for lupus nephritis. J Am Soc Nephrol. 31:1335–1347. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun PP, Zhou XJ, Su JQ, Wang C, Yu XJ, Su T, Liu G, Wang SX, Nie J and Yang L: Urine macrophages reflect kidney macrophage content during acute tubular interstitial and glomerular injury. Clin Immunol. 205:65–74. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Rubio-Navarro A, Carril M, Padro D, Guerrero-Hue M, Tarín C, Samaniego R, Cannata P, Cano A, Villalobos JM, Sevillano ÁM, et al: CD163-Macrophages are involved in rhabdomyolysis-induced kidney injury and may be detected by MRI with targeted gold-coated iron oxide nanoparticles. Theranostics. 6:896–914. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li D, Yan Sun W, Fu B, Xu A and Wang Y: Lipocalin-2-The myth of its expression and function. Basic Clin Pharmacol Toxicol. 127:142–151. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Rahimi S, Roushandeh AM, Ahmadzadeh E, Jahanian-Najafabadi A and Roudkenar MH: Implication and role of neutrophil gelatinase-associated lipocalin in cancer: Lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types. Mol Biol Rep. 47:2327–2346. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Santiago-Sánchez GS, Pita-Grisanti V, Quiñones-Díaz B, Gumpper K, Cruz-Monserrate Z and Vivas-Mejía PE: Biological functions and therapeutic potential of lipocalin 2 in cancer. Int J Mol Sci. 21:43652020. View Article : Google Scholar | |
|
Desanti De Oliveira B, Xu K, Shen TH, Callahan M, Kiryluk K, D'Agati VD, Tatonetti NP, Barasch J and Devarajan P: Molecular nephrology: Types of acute tubular injury. Nat Rev Nephrol. 15:599–612. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Urbschat A, Thiemens AK, Mertens C, Rehwald C, Meier JK, Baer PC and Jung M: Macrophage-secreted Lipocalin-2 promotes regeneration of injured primary murine renal tubular epithelial cells. Int J Mol Sci. 21:20382020. View Article : Google Scholar : PubMed/NCBI | |
|
Mertens C, Kuchler L, Sola A, Guiteras R, Grein S, Brüne B, von Knethen A and Jung M: Macrophage-derived iron-bound lipocalin-2 correlates with renal recovery markers following sepsis-induced kidney damage. Int J Mol Sci. 21:75272020. View Article : Google Scholar : PubMed/NCBI | |
|
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y and Zychlinsky A: Neutrophil extracellular traps kill bacteria. Science. 303:1532–1535. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Doster RS, Rogers LM, Gaddy JA and Aronoff DM: Macrophage extracellular traps: A scoping review. J Innate Immun. 10:3–13. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Nakazawa D, Marschner JA, Platen L and Anders HJ: Extracellular traps in kidney disease. Kidney Int. 94:1087–1098. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hartl D: Macrophages and platelets join forces to release kidney-damaging DNA traps. Nat Med. 24:128–129. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Okubo K, Kurosawa M, Kamiya M, Urano Y, Suzuki A, Yamamoto K, Hase K, Homma K, Sasaki J, Miyauchi H, et al: Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury. Nat Med. 24:232–238. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lichtman A: The kidney gets caught in a macrophage trap. Sci Immunol. 3:eaat37452018. View Article : Google Scholar : PubMed/NCBI | |
|
Satoh T, Kidoya H, Naito H, Yamamoto M, Takemura N, Nakagawa K, Yoshioka Y, Morii E, Takakura N, Takeuchi O and Akira S: Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature. 495:524–528. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Eyers PA, Keeshan K and Kannan N: Tribbles in the 21st century: The evolving roles of tribbles pseudokinases in biology and disease. Trends Cell Biol. 27:284–298. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu ZZ, Han ZD, Liang YK, Chen JX, Wan S, Zhuo YJ, Cai ZD, Deng YL, Lin ZY, Mo RJ, et al: TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer. Cell Signal. 59:152–162. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Shiraishi M, Shintani Y, Shintani Y, Ishida H, Saba R, Yamaguchi A, Adachi H, Yashiro K and Suzuki K: Alternatively activated macrophages determine repair of the infarcted adult murine heart. J Clin Invest. 126:2151–2166. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Arndt L, Dokas J, Gericke M, Kutzner CE, Müller S, Jeromin F, Thiery J and Burkhardt R: Tribbles homolog 1 deficiency modulates function and polarization of murine bone marrow-derived macrophages. J Biol Chem. 293:11527–11536. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xie X, Yang X, Wu J, Ma J, Wei W, Fei X and Wang M: Trib1 contributes to recovery from ischemia/reperfusion-induced acute kidney injury by regulating the polarization of renal macrophages. Front Immunol. 11:4732020. View Article : Google Scholar : PubMed/NCBI | |
|
Hughes CE and Nibbs RJB: A guide to chemokines and their receptors. FEBS J. 285:2944–2971. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ruytinx P, Proost P, Van Damme J and Struyf S: Chemokine-induced macrophage polarization in inflammatory conditions. Front Immunol. 9:19302018. View Article : Google Scholar : PubMed/NCBI | |
|
Lu J, Chatterjee M, Schmid H, Beck S and Gawaz M: CXCL14 as an emerging immune and inflammatory modulator. J Inflamm (Lond). 13:12016. View Article : Google Scholar : PubMed/NCBI | |
|
Lv J, Wu ZL, Gan Z, Gui P and Yao SL: CXCL14 overexpression attenuates sepsis-associated acute kidney injury by inhibiting proinflammatory cytokine production. Mediators Inflamm. 2020:24317052020. View Article : Google Scholar : PubMed/NCBI | |
|
Yoo KD, Cha RH, Lee S, Kim JE, Kim KH, Lee JS, Kim DK, Kim YS and Yang SH: Chemokine receptor 5 blockade modulates macrophage trafficking in renal ischaemic-reperfusion injury. J Cell Mol Med. 24:5515–5527. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Q, Wang Y, Pei G, Deng X, Jiang H, Wu J, Zhou C, Guo Y, Yao Y, Zeng R and Xu G: Bone marrow-derived Ly6C(−) macrophages promote ischemia-induced chronic kidney disease. Cell Death Dis. 10:2912019. View Article : Google Scholar : PubMed/NCBI | |
|
Rudemiller NP, Patel MB, Zhang JD, Jeffs AD, Karlovich NS, Griffiths R, Kan MJ, Buckley AF, Gunn MD and Crowley SD: C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent kidney injury by limiting renal macrophage infiltration. Am J Pathol. 186:2846–2856. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Prakoura N and Chatziantoniou C: Periostin in kidney diseases. Cell Mol Life Sci. 74:4315–4320. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wallace DP: Periostin in the kidney. Adv Exp Med Biol. 1132:99–112. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kormann R, Kavvadas P, Placier S, Vandermeersch S, Dorison A, Dussaule JC, Chadjichristos CE, Prakoura N and Chatziantoniou C: Periostin promotes cell proliferation and macrophage polarization to drive repair after AKI. J Am Soc Nephrol. 31:85–100. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Roedig H, Nastase MV, Wygrecka M and Schaefer L: Breaking down chronic inflammatory diseases: The role of biglycan in promoting a switch between inflammation and autophagy. FEBS J. 286:2965–2979. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Roedig H, Nastase MV, Frey H, Moreth K, Zeng-Brouwers J, Poluzzi C, Hsieh LT, Brandts C, Fulda S, Wygrecka M and Schaefer L: Biglycan is a new high-affinity ligand for CD14 in macrophages. Matrix Biol. 77:4–22. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Poluzzi C, Nastase MV, Zeng-Brouwers J, Roedig H, Hsieh LT, Michaelis JB, Buhl EM, Rezende F, Manavski Y, Bleich A, et al: Biglycan evokes autophagy in macrophages via a novel CD44/Toll-like receptor 4 signaling axis in ischemia/reperfusion injury. Kidney Int. 95:540–562. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Meissner M, Viehmann SF and Kurts C: DAMPening sterile inflammation of the kidney. Kidney Int. 95:489–491. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Roedig H, Damiescu R, Zeng-Brouwers J, Kutija I, Trebicka J, Wygrecka M and Schaefer L: Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development. Semin Cancer Biol. 62:31–47. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang PL and Liu ML: Extracellular vesicles mediate cellular interactions in renal diseases-Novel views of intercellular communications in the kidney. J Cell Physiol. 2021.(Epub ahead of print). View Article : Google Scholar | |
|
Rigalli JP, Barros ER, Sommers V, Bindels RJM and Hoenderop JGJ: Novel aspects of extracellular vesicles in the regulation of renal physiological and pathophysiological processes. Front Cell Dev Biol. 8:2442020. View Article : Google Scholar : PubMed/NCBI | |
|
Wu P, Zhang B, Ocansey DKW, Xu W and Qian H: Extracellular vesicles: A bright star of nanomedicine. Biomaterials. 269:1204672020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Zhang H, Gu J, Zhang J, Shi H, Qian H, Wang D, Xu W, Pan J and Santos HA: Engineered extracellular vesicles for cancer therapy. Adv Mater e2005709. 2021.(Epub ahead of print). PubMed/NCBI | |
|
Quaglia M, Dellepiane S, Guglielmetti G, Merlotti G, Castellano G and Cantaluppi V: Extracellular vesicles as mediators of cellular crosstalk between immune system and kidney graft. Front Immunol. 11:742020. View Article : Google Scholar : PubMed/NCBI | |
|
Tang TT, Wang B, Wu M, Li ZL, Feng Y, Cao JY, Yin D, Liu H, Tang RN, Crowley SD, et al: Extracellular vesicle-encapsulated IL-10 as novel nanotherapeutics against ischemic AKI. Sci Adv. 6:eaaz07482020. View Article : Google Scholar : PubMed/NCBI | |
|
Console L, Scalise M and Indiveri C: Exosomes in inflammation and role as biomarkers. Clin Chim Acta. 488:165–171. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ståhl AL, Johansson K, Mossberg M, Kahn R and Karpman D: Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases. Pediatr Nephrol. 34:11–30. 2019. View Article : Google Scholar | |
|
Thongboonkerd V: Roles for exosome in various kidney diseases and disorders. Front Pharmacol. 10:16552020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang ZW and Zhu X: Exosomal miR-19b-3p communicates tubular epithelial cells and M1 macrophage. Cell Death Dis. 10:7622019. View Article : Google Scholar : PubMed/NCBI | |
|
Lv LL, Feng Y, Wu M, Wang B, Li ZL, Zhong X, Wu WJ, Chen J, Ni HF, Tang TT, et al: Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ. 27:210–226. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Li ZL, Lv LL, Tang TT, Wang B, Feng Y, Zhou LT, Cao JY, Tang RN, Wu M, Liu H, et al: HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation. Kidney Int. 95:388–404. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Harrois A, Soyer B, Gauss T, Hamada S, Raux M and Duranteau J: Prevalence and risk factors for acute kidney injury among trauma patients: A multicenter cohort study. Crit Care. 22:3442018. View Article : Google Scholar : PubMed/NCBI | |
|
Zuk A and Bonventre JV: Acute kidney injury. Annu Rev Med. 67:293–307. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Wen Y and Crowley SD: The varying roles of macrophages in kidney injury and repair. Curr Opin Nephrol Hypertens. 29:286–292. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Tang PM, Nikolic-Paterson DJ and Lan HY: Macrophages: Versatile players in renal inflammation and fibrosis. Nat Rev Nephrol. 15:144–158. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Poeck H, Bscheider M, Gross O, Finger K, Roth S, Rebsamen M, Hannesschläger N, Schlee M, Rothenfusser S, Barchet W, et al: Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol. 11:63–69. 2010. View Article : Google Scholar : PubMed/NCBI |
